8-K//Current report
Eterna Therapeutics Inc. 8-K
Accession 0001641172-25-002514
$ERNACIK 0000748592operating
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 8:55 AM ET
Size
797.9 KB
Accession
0001641172-25-002514
Documents
- 8-Kform8-k.htmPrimary
- EX-10.1ex10-1.htm
- EX-10.2ex10-2.htm
- EX-10.3ex10-3.htm
- EX-101.SCHerna-20250331.xsd
XBRL SCHEMA FILE
- EX-101.LABerna-20250331_lab.xml
XBRL LABEL FILE
- EX-101.PREerna-20250331_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001641172-25-002514-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLform8-k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Ernexa Therapeutics Inc.
CIK 0000748592
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000748592
Filing Metadata
- Form type
- 8-K
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 8:55 AM ET
- Size
- 797.9 KB